$100.85 +1.94 (%) Pacira Pharmaceuticals Inc - NASDAQ

Oct. 21, 2014 | 04:00 PM

Partner Headlines

  1. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  2. Pacira Pharma Offers Added Data Support Safety of EXPAREL in Peripheral Nerve Block

    Benzinga | Oct. 13, 2014 | 16:00PM EST
  3. Bank Of America Sees Significant Manufacturing Capacity Expansions Underway For Pacira Pharmaceuticals

    Benzinga | Oct. 8, 2014 | 11:13AM EST
  4. NASDAQ Dips 1.5%; HB Fuller Shares Decline On Downbeat Results

    Benzinga | Sep. 25, 2014 | 12:09PM EST
  5. Markets Tumble; Scholastic Posts Wider Fiscal-First Quarter Loss

    Benzinga | Sep. 25, 2014 | 11:12AM EST
  6. Morning Market Losers

    Benzinga | Sep. 25, 2014 | 09:44AM EST
  7. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 25, 2014 | 08:11AM EST
  8. US Stock Futures Flat Ahead Of Jobless Claims, Durable-Goods Orders Data

    Benzinga | Sep. 25, 2014 | 07:35AM EST
  9. Pacira Pharmaceuticals, Inc. Announces Receipt of FDA Warning Letter

    Benzinga | Sep. 25, 2014 | 06:59AM EST
  10. Pacira Pharmaceuticals

    IBD | Jul. 31, 2014 | 18:53PM EST
  11. UPDATE: Bank Of America Reiterates On Pacira Pharmaceuticals On Positive Survey Results

    Benzinga | Jul. 17, 2014 | 08:33AM EST
  12. 3 Hot Biotech Stocks Hitting Highs

    Benzinga | Jun. 23, 2014 | 14:00PM EST
  13. UPDATE: JMP Securities Initiates Coverage On Pacira Pharmaceuticals

    Benzinga | Jun. 17, 2014 | 10:43AM EST
  14. Sohn Conference Moves Markets Once Again

    Benzinga | May. 6, 2014 | 16:56PM EST
  15. Benzinga's Volume Movers

    Benzinga | Apr. 9, 2014 | 10:22AM EST
  16. CorMedix Welcomes Additional Board Members

    Benzinga | Apr. 7, 2014 | 08:33AM EST
  17. Mid-Morning Market Update: Markets Open Higher; UTi Worldwide Reports Q4 Loss

    Benzinga | Mar. 31, 2014 | 10:35AM EST
  18. Baron Funds Comments on Pacira Pharmaceuticals

    GuruFocus | Mar. 5, 2014 | 11:26AM EST
  19. UPDATE: Piper Jaffray Downgrades Pacira Pharmaceuticals Following 2Q13 Net Loss

    Benzinga | Aug. 7, 2013 | 08:18AM EST
  20. Pacira Pharma Shares Sink as Co. Announces EXPAREL Phase 3 Trial Does Not Meet Primary Endpoint

    Benzinga | Aug. 1, 2013 | 17:36PM EST
  21. UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Pacira Pharmaceuticals

    Benzinga | Jan. 18, 2013 | 03:52AM EST
  22. Pacira Pharma Prices $110M Private Offering of Convertible Notes

    Benzinga | Jan. 17, 2013 | 01:07AM EST
  23. Pacira Pharmaceuticals Announces Proposed Offering of $100 Million of Convertible Senior Notes

    Benzinga | Jan. 15, 2013 | 09:00AM EST
  24. Health Care Sector Wrap

    FoxBusiness | Aug. 28, 2012 | 10:43AM EST
  25. Health Care Sector Wrap

    FoxBusiness | Aug. 14, 2012 | 10:46AM EST
  26. Health Care Sector Wrap

    FoxBusiness | Aug. 9, 2012 | 10:40AM EST
  27. Dollar General, Questcor Pharmaceuticals Among Stocks Setting 52-Week Highs Monday

    FoxBusiness | Jun. 25, 2012 | 10:33AM EST
  28. Arena Pharmaceuticals, Merck &, Other Stocks Hit 52-Week Highs Thursday

    FoxBusiness | Jun. 21, 2012 | 06:33AM EST
  29. Pacira Pharmaceuticals Announces EXPAREL Expected to be Commercially Available in April 2012

    Benzinga | Jan. 8, 2012 | 23:51PM EST
  30. Pacira Pharmaceuticals Announces Results from EXPAREL Pivotal Trial Published in Diseases of the Colon & Rectum

    Benzinga | Dec. 18, 2011 | 23:52PM EST
Trading Center